Cargando…
Jianpi Qinghua Fomula alleviates insulin resistance via restraining of MAPK pathway to suppress inflammation of the small intestine in DIO mice
BACKGROUND: Jianpi Qinghua Fomula (JPQHF), a clinically proven prescription,has been applied to cure insulin resistance(IR) and type 2 diabetes (T2DM) for more than 20 years. Here, we will unravel the underlying molecular mechanisms relevant to the therapeutic actions of JPQHF. METHODS: High-fat(HF)...
Autores principales: | Liu, Yahua, Han, Xu, Cai, Mengjie, Jin, Shenyi, Yan, Zihui, Lu, Hao, Chen, Qingguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088054/ https://www.ncbi.nlm.nih.gov/pubmed/35534842 http://dx.doi.org/10.1186/s12906-022-03595-0 |
Ejemplares similares
-
JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice
por: Tian, Jing, et al.
Publicado: (2023) -
The Efficacy and Mechanism of Qinghua Jianpi Recipe in Inhibiting Canceration of Colorectal Adenoma Based on Inflammatory Cancer Transformation
por: Liu, Ting, et al.
Publicado: (2023) -
Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population
por: Jin, Shenyi, et al.
Publicado: (2022) -
Network pharmacology and molecular docking reveal the mechanism of Qinghua Xiaoyong Formula in Crohn’s disease
por: Fang, Chenyang, et al.
Publicado: (2023) -
Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1
por: Chen, Yanzhen, et al.
Publicado: (2023)